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dhanges in the Frontotemporal Cortex and Cognitive
orrelates in First-Episode Psychosis
eticia Gutiérrez-Galve, Claudia A.M. Wheeler-Kingshott, Daniel R. Altmann, Gary Price, Elvina M. Chu,
erity C. Leeson, Antonio Lobo, Gareth J. Barker, Thomas R.E. Barnes, Eileen M. Joyce, and María A. Ron
ackground: Loss of cortical volume in frontotemporal regions has been reported in patients with schizophrenia and their relatives.
ortical area and thickness are determined by different genetic processes, and measuring these parameters separately may clarify
isturbances in corticogenesis relevant to schizophrenia. Our study also explored clinical and cognitive correlates of these parameters.
ethods: Thirty-seven patients with first-episode psychosis (34 schizophrenia, 3 schizoaffective disorder) and 38 healthy control subjects
atched for age and sex took part in the study. Imaging was performed on an magnetic resonance imaging 1.5-T scanner. Area and
hickness of the frontotemporal cortex were measured using a surface-based morphometry method (Freesurfer). All subjects underwent
europsychologic testing that included measures of premorbid and current IQ, working and verbal memory, and executive function.
esults: Reductions in cortical area,moremarked in the temporal cortex,werepresent inpatients.Overall frontotemporal cortical thickness
id not differ between groups, although regional thinning of the right superior temporal region was observed in patients. There was a
ignificant association of both premorbid IQ and IQ at disease onset with area, but not thickness, of the frontotemporal cortex, andworking
emory spanwas associatedwith area of the frontal cortex. These associations remained significantwhen only patientswith schizophrenia
ere considered.
onclusions: Our results suggest an early disruption of corticogenesis in schizophrenia, although the effect of subsequent environmental
actors cannot be excluded. In addition, cortical abnormalities are subject to regional variations and differ from those present in neurode-
enerative diseases.eyWords:Cognitive impairment, cortical area and thickness, first-
pisode psychosis, frontotemporal cortex, magnetic resonance im-
ging, surface-based morphometry
ortical volume is genetically determined with heritability
(1) decreasing over time as environmental factors become
relevant (2). The cortex is shaped in utero by the strength
f interregional connectivity, and cortical changes are to be
xpected in schizophrenia, a disease with abnormal brain con-
ectivity (3,4).
Meta-analyses of voxel-based morphometry studies identified
ray matter loss in corticosubcortical networks involving fronto-
emporal and limbic cortex, thalamus, and striatum in chronic
chizophrenia (5–7), and less extensive changes have also been
eported in those with first-episode (8), schizotypal disorder, and
igh-risk individuals (9–12). Subtle cortical abnormalities, with-
ut volume loss, have been described using magnetization
ransfer imaging in first-episode psychosis (13,14).
Surface-based morphometry (SBM) methods allow the inde-
endent measurement of cortical area and thickness—indexes
hat share a high heritability but are determined by different
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oi:10.1016/j.biopsych.2010.03.019genetic mechanisms (15). Freesurfer (16), an SBM method with
realistic cortical reconstruction that allows for manual correction
of topological errors (17), uses a segmentation procedure based
on the identification of gray–white matter and gray matter–pial
boundaries, as well as a surface-based registration that aligns
cortical folding patterns. Freesurfer has an accuracy of .2 mm (18)
compared with postmortem measures of cortical thickness and
has been validated using different scanners and magnetic reso-
nance imaging (MRI) protocols (16).
Studies using SBM have mainly measured regional or whole
cortical thickness. Frontotemporal gyral and sulcal thinning has
been reported in children and adolescents (19,20) and in young
adults with first-episode schizophrenia by some (21,22) but not
others (23). Cortical thinning, particularly prefrontal, followed a
developmental trajectory different from that of control subjects
(24,25). In chronic patients, thinning of the entorhinal (26) and
frontotemporal cortex with relative sparing of somatosensory
(27) and parietal cortex (28) has also been reported and changes
in cortical thickness in the cingulate and temporal regions may
represent the unexpressed genetic liability in relatives of schizo-
phrenia patients (29).
Cortical area has been less frequently measured with contra-
dictory results. Thus, although reduced area in paralimbic ventral
frontal cortex in drug-naive patients (30) and in posterior cingu-
late in those with chronic schizophrenia and their relatives has
been described (31), other studies (32) have reported area
increases in the anterior cingulate. Early reports of decreased
insular area in first-episode patients (30) have not been repli-
cated (33). A study of patients with adolescent-onset schizophre-
nia (34) identified widespread, regionally variable cortical pa-
thology in prefrontal and superior temporal gyrus, with variable
reductions in area and/or thickness. Similar changes have been
reported in unaffected relatives (35), and severity of positive symp-
toms has been associated with decrease entorhinal area (26).We report here an exploratory study in patients with first-
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wpisode psychosis in whom cortical area and thickness were
easured using SBM in frontal and temporal cortex, regions
nown to be implicated in schizophrenia. We aimed to clarify the
attern of cortical abnormalities, whether changes in area and
ortical thickness occurred independently, and their possible
ssociations with clinical and cognitive measures.
ethods andMaterials
ubjects
Patients were part of a cohort recruited for the West London
ongitudinal First-Episode Psychosis Study (36), aged between
6 and 49 years at recruitment, who had been receiving antipsy-
hotic medication for less than 12 weeks. Diagnosis was ascer-
ained using the diagnostic module of the Diagnostic Interview
or Psychosis (DIP-DM) (37), which includes items from the
perational Criteria Checklist for Psychosis (38) and the World
ealth Organization Schedules for Clinical Assessment in Neu-
opsychiatry (39). Two nurses trained by an experienced psychi-
trist (T.R.E.B.) conducted the interviews.
Forty-one patients who had MRI and neuropsychologic as-
essments participated. Four were excluded because of poor-
uality MRI data. Thirty-seven patients (25 males) were included;
4 had a final diagnosis of schizophrenia and 3 had schizoaffec-
ive disorder (1 bipolar, 2 depressed subtypes). Mean age was
6.8 years (SD  8.8; range, 16–49). The study was naturalistic
ith no restrictions on prescribed medication; all patients were
rescribed antipsychotics (36 second-generation, 1 first-genera-
ion), and 8 were also prescribed antidepressants. At the time of
canning, the median duration of treatment was 102 days (range,
384), and 17 patients had received treatment for more than 12
eeks. Thirty-eight healthy subjects (22 males) who had neuro-
sychologic assessment and MRI served as control subjects. Their
ean age was 25.0 years (SD  5.4; range, 16–37). Exclusion
riterion for all subjects, was the presence of a medical or
eurological illness, including head injury leading to uncon-
ciousness. Controls with psychiatric illness in themselves or
heir first-degree relatives were excluded.
linical Ratings
Mental state was assessed with the Scales for the Assessment
f Positive and Negative Symptoms (SAPS and SANS) (40,41).
nterrater agreement (linearly weighted kappa) was assessed
sing a standard set of videotaped interviews. Using global
ubscale items, linearly weighted kappas of .76 for SAPS and .74
or SANS were achieved (42). Scores for the three symptom-
erived syndromes (negative, positive, and disorganization)
ere calculated (43). Affective symptoms were measured with
he Young Mania Scale (44) and Hamilton Rating Scale for
epression (45). Age of onset and duration of untreated psycho-
is (DUP) were established using the Symptom Onset in Schizo-
hrenia Inventory (46). Alcohol and drug use were assessed
sing the DIP (37), and criteria for abuse and dependence using
he Alcohol and Drug Use Scales (47). None of the subjects
ulfilled these criteria. Handedness was assessed using the Annett
cale (48).
Ethical permission was obtained from the local ethics com-
ittees. Participants gave written informed consent according to
he Declaration of Helsinki and received an honorarium.
europsychological Assessment
Premorbid IQ was estimated using the Revised National Adult
eading Test (49), validated in schizophrenia (50,51). Current IQ
as measured using a short form of the Wechsler Adult Intelli-
ww.sobp.org/journalgence Scale—III (52) validated for schizophrenia (53), compris-
ing the Information, Arithmetic, Block Design, and Digit Symbol
subtests. Measures of executive function were derived from the
Cambridge Neuropsychological Test Automated Battery (54): 1)
Working memory span, from the Spatial Span Task, measures the
ability to remember the order of sequences of colored squares
presented in increasing numbers. The span was measured as the
highest number recalled correctly. 2) Working memory manip-
ulation, from the Spatial Working Memory Task, a self-ordered
search task measures the ability to remember the location of
previously found “tokens” while searching for new ones. An
error occurs when a participant returns to the location where a
token has already been found. Total errors were used as an index
of working memory manipulation. 3) Planning, from the Stock-
ings of Cambridge task (55), measures the ability to move
colored “balls” in an arrangement displayed on the screen to
match a goal arrangement. The number of problems solved in
the minimum number of moves possible was the score.
Verbal memory was assessed with the Rey Auditory Verbal
Learning Test (56). The participant is asked to recall nouns from
a list of 15 immediately after each of five trials. The number of
words recalled over the five trials was the final score.
MRI Data Acquisition
The MRIs were performed on a GE Signa 1.5-Tesla scanner
(General Electric, Milwaukee, Wisconsin), using a standard
quadrature head coil. T1-weighted volumetric images were
obtained using an inversion recovery spoiled gradient-recalled
echo sequence with an isotropic voxel size of 1.2  1.2  1.2
mm3. One hundred twenty-four axial contiguous slices were
acquired. Other parameters were echo time (5.4 msec), repetition
time (15 msec), inversion time (450 msec), field of view  31  16
cm2, acquisition matrix 256  128, number of averages  1,
excitation flip angle 15°, and receiver bandwidth 15.63 kHz.
Image Processing
A rater (L.G.G.), blind to participant status, used Freesurfer
4.0.1 (http://surfer.nmr.mgh.harvard.edu) to generate maps of
surface area and cortical thickness in standard Montreal Neuro-
logical Institute (MNI) space (57,58). After skull stripping and
white matter segmentation, the cortical surface of each hemi-
sphere was inflated to an average spherical surface to locate the
pial surface and the gray–white matter boundary (57). The
distance between the two at each vertex (i.e., surface point)
across the cortex is considered a measure of cortical thickness.
Cortical maps are smoothed with a 10-mm full-width at half-
maximum Gaussian kernel and aligned to a common surface
template using a high-resolution surface-based averaging tech-
nique, and 32 cortical parcellations are automatically generyated
(59). The only manual step was the correction of topological
errors when the above steps had been completed. Total brain
volume was estimated using Freesurfer (60).
Analysis of Cortical Parameters
Two comparisons were made between patients and controls:
1) whole-brain cortical thickness using the “vertex-by-vertex”
analysis; and 2) cortical thickness, surface area, and volume in
frontal and temporal regions.
From the Desikan template (59), six frontal and six temporal
parcellations in each hemisphere were selected. Superior frontal,
pars opercularis, caudal middle frontal, rostral middle frontal,
caudal anterior cingulate, and rostral anterior cingulate were
selected in the frontal lobe; in the temporal lobe, the superior,
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L. Gutiérrez-Galve et al. BIOL PSYCHIATRY 2010;68:51–60 53iddle, and inferior temporal, fusiform, temporal pole, and
ransverse temporal parcellations were selected (Figure 1). Av-
rage thickness, total surface area, and volume of the cortex for
he frontal and temporal regions covered by these parcellations
ere calculated for each hemisphere and compared between the
wo groups.
tatistical Analysis
Demographic and Cognitive Variables. Age, sex, total brain
olume, and handedness were compared between groups using
and chi-square tests. Linear regression models adjusted by age
nd sex were used to compare cognitive scores.
Imaging Variables. Age and sex were used as covariates in
ll models.
For the comparison of whole brain cortical thickness, the
ertex-by-vertex analysis was used, and means of cortical thick-
ess were compared between groups using a two-tailed t test;
ortical thickness was modeled as a function of group controlling
or age and sex. Corrections for multiple comparisons were made
sing a false discovery rate (FDR), setting the level of significance
t .05 (61).
Linear mixed models were used for the following compari-
ons of frontal and temporal cortical parameters between the
roups: 1) differences due to diagnostic group, region, and side,
ith two-way interactions (diagnosis by region, diagnosis by
ide, and region by side); 2) differences due to sex; age; duration
f treatment; DUP; and positive, negative, and disorganization
yndrome scores with two-way interactions by region and side;
nd 3) associations between cognitive scores and cortical param-
ters with two- and three-way interactions. Region was entered
s a within-subject effect and diagnosis, cognitive scores, sex,
nd age as between-subject effects. Three separate models were
reated for thickness, surface area, and cortical volume that
llowed the inclusion of multiple measurements for each subject
nd the handling of missing data, thereby increasing statistical
ower (62). As in previous studies (27,34,63), we did not control
or brain volume, a schizophrenia-related variable, because this
ould have obscured possible group differences.
We repeated the same model with two-way interaction (di-
gnosis by region) to identify cortical differences in each of the
ix frontal or temporal parcellations. When significant interac-
ions were present, the linear mixed model was repeated with
he corresponding indicators and interaction terms for the re-
ional parcellations.
For these exploratory analyses significance was reported at
he 5% level with no formal adjustment made for multiple
omparisons, because this may be inappropriate (64,65) when
igure 1. Lateral andmidsagittal views of the frontal and temporal parcella
percularis; 5, rostral anterior cingulate; 6, caudal anterior cingulate; 7, sup
1, temporal pole; 12, fusiform.o single null hypothesis covers the multiple tests. To highlightthe strongest associations, we also report the linear regression
results using FDR setting the level of significance at .05.
Results
Age, total brain volume, and sex did not differ between
groups. Fewer patients (2 of 37) than control subjects (7 of 38)
were left-handed, although this difference was not statistically
significant. All cognitive scores were significantly worse in
patients (at trend level for premorbid IQ; Table 1). Duration of
treatment and DUP, positive, negative, and disorganization
scores are shown on Table 1.
Group Differences in Cortical Parameters
Analyses were performed with and without three patients
with schizoaffective disorder. Results remained unchanged when
the latter were excluded and findings for the whole group are
reported (Table 2).
Whole-brain cortical thickness (vertex by vertex) did not
differ between groups.
Cortical parameters in frontal and temporal regions: 1) Corti-
cal thickness did not vary by diagnosis or sex. Age was more
closely associated with thinning in the frontal than in the
temporal cortex (regional mean difference in thinning per year
.0085 mm/year; 95% confidence interval [CI].0113 to.0057;
p  .001], with thinning of .0073 mm/year (95% CI .0109 to
.0038; p  .001) in the frontal region. 2) Cortical area was not
related to age or side in frontal or temporal regions but was larger
in male subjects irrespective of diagnosis (regional mean differ-
ence between males and females  416.13 mm2; 95% CI 153.16
to 679.09); p  .002) and more so for the frontal (sex mean
difference  2679.29 mm2; 95% CI 1995.44 to 3363.13; p  .001)
than the temporal regions (sex mean difference  2263.16 mm2;
95% CI 1579.32 to 2947.01; p  .001). In patients, temporal
cortical area was smaller than in controls (regional means
difference in patients  724.12 mm2; 95% CI –1369.56 to
–78.69; p  .028), explained by the smaller area in the superior
(95% CI –326.42 to –67.32; p  .003), middle (95% CI 291.31 to
32.21; p  .014) and inferior (95% CI 271.43 to 12.33; p 
.032) temporal parcellations. FDR-corrected analysis showed a
reduction in right superior temporal area in patients (mean
difference between patients and control subjects  206.74
mm2; 95% CI 354.87 to 58.62); p  .028). In a post hoc
multiple linear regressions of cortical thickness in these three
parcellations, adjusted for age and sex, thickness was only
reduced in the right superior temporal parcellation (mean differ-
ence between patients and control subjects  .0751 mm; 95%
1, superior frontal; 2, rostral middle frontal; 3, caudal middle frontal; 4, pars
emporal; 8, middle temporal; 9, inferior temporal; 10, transverse temporal;tions:CI .1363 to .0139; p  .017). There were no significant
www.sobp.org/journal
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wifferences in frontal cortical area between groups. 3) Temporal
ortical volume was smaller in patients (regional mean difference
n patients  2183.94 mm3; 95% CI 4104.17 to 263.70; p 
026), explained by reductions in the volume of the superior
95% CI 1052.96 to 216.31; p  .003), middle (95% CI
936.38 to99.73; p .015), inferior temporal (95% CI938.57
o101.92; p .015), and fusiform (95% CI939.37 to102.72;
 .015) parcellations. Left frontal cortical volume was larger
han right (mean difference between sides 740.47 mm3; 95% CI
2.03 to 1438.91; p  .038). There were no group differences in
he temporal cortical volume (mean difference between sides 
218.41 mm3; 95% CI 916.85 to 480.03; p  .540). 4) Cortical
arameters were not associated with duration of treatment or
UP or syndrome scores. In a post hoc analysis of parcellations
ith reduced cortical area, using linear regressions adjusted for
UP, age, and sex, a trend level association with treatment
uration (area increase of 1.46 mm2/day of untreated psychosis;
5% CI .04 to 2.97; p  .056) was present for the superior
emporal parcellation.
ortical Parameters and Cognition
Whole group and the schizophrenia-only subgroup results are
iven for working memory because minor differences occurred
hen schizoaffective disorder patients were excluded.
Premorbid IQ. In patients there was a significant association
etween cortical area and premorbid IQ for frontal and temporal
egions (mean difference of regional area increase per IQ point
6.04 mm2; 95% CI8.35 to 20.43; p .411). Higher premorbid
Q was associated with larger frontal cortical area (increase of
able 1. Demographic and Cognitive Measures in Patients and Controls
ariable Measured Patients (n 37)
ge (years) 26.8 (8.8) [16–49]
ale Sex, n (%) 25 (67.6)
eft-Handed, n (%) 2 (5.4)
otal Brain Volume (mm3) 1543685 (198405.4)
remorbid IQ 99.8 (12.9) [73–12
urrent IQ 89.6 (17.6) [61–13
orking Memory Span 5.5 (1.6) [2–9]
lanning 7.2 (2.7) (012)
orking Memory Manipulation 33.9 (16.7) (058)
ey Auditory Verbal Learning Test 38 (8.4) [14–52]
uration of Treatment (days) 80 (56) [9–186]
uration of Untreated Psychosis (months) 10.4 (22.8) (0126
actor 1, Negative Syndrome .29 (.25) (0.8)
actor 2, Positive Syndrome .75 (.20) (01)
actor 3, Disorganization Syndrome .27 (.25) (0.8)
Values are means (SD) [range].
NA, not applicable.
able 2. Cortical Parameters in Frontal and Temporal Regions in Patients a
egion of
ortex
Thickness (mm)a Surface A
Patients Controls Patients
rontal
Left 2.71 (.15) 2.70 (.13) 15680.59 (2086.42)
Right 2.73 (.15) 2.69 (.13) 15567.30 (2252.66)
emporal
Left 2.72 (.13) 2.71 (.11) 13782.35 (1557.68)
Right 2.73 (.15) 2.75 (.12) 13795.49 (1652.54)
aValues are means (SD).
bValues are means (SD) of the sums of six parcellations each.
ww.sobp.org/journal46.01 mm2 per premorbid IQ point; 95% CI 11.13 to 80.88; p 
.010) accounted for by superior frontal parcellation (95% CI 2.91
to 23.05; p  .012). Higher premorbid IQ was associated with
larger temporal cortical area (increase of 39.97 mm2; 95% CI 5.09
to 74.84; per IQ point; p  .025). The middle (95% CI 3.28 to
17.48; p .004), inferior temporal (95% CI .41 to 14.61; p .038),
and fusiform (95% CI 4.19 to 18.39; p  .002) parcellations
accounted for this association. No such associations were present
in control subjects (Figures 2–6). No significant associations
survived FDR correction.
In patients, there was a significant association between corti-
cal volume and premorbid IQ for both frontal and temporal
regions (mean difference of regional volume increase per IQ
point  26.80 mm3; 95% CI 27.26 to 80.87; p  .311). Higher
premorbid IQ was associated with larger frontal cortical volume
(increase of 151.87 mm3 per IQ point; 95% CI 48.91 to 254.84; p
 .004) accounted for by the volumes of the superior (95% CI
23.40 to 81.83; p .001) and rostral middle (95% CI 2.85 to 61.28;
p .031) parcellations. Higher premorbid IQ was also associated
with temporal cortical volume (increase of 125.07 mm3 per IQ
point; 95% CI 22.11 to 228.03; p .017). The volumes in superior
(95% CI 5.69 to 51.32; p  .014), middle (95% CI 12.61 to 58.25;
p  .002), inferior (95% CI .36 to 45.99; p  .047), and fusiform
(95% CI 13.94 to 59.58; p  .002) parcellations accounted for the
association. These associations were not present in controls.
Current IQ. In patients, current IQ had a stronger association
with frontal than temporal cortical area (mean difference of
regional area increase per IQ point  14.56 mm2; 95% CI 4.13 to
Control Subjects (n 38) Comparison
25.0 (5.4) [16–37] t(73)1.06, p .291
22 (57.9) 2(1) .75, p .387
7 (18.4) 2(1) 3.01, p .083
1571956 (188197.2) t(73) .63, p .529
105.3 (11.2) [74–120] t(74)1.99, p .051
110.6 (15.0) [81–140] t(74)5.63, p .001
6.5 (1.2) [4–9] t(74)3.24, p .002
8.8 (1.6) [6–12] t(74)3.12, p .003
15.4 (14.3) (060) t(74) 5.26, p .001
49.4 (10.4) [18–64] t(74)5.03, p .001
NA NA
NA NA
NA NA
NA NA
NA NA
ntrols Unadjusted by Age or Gender
mm2)b Volume (mm3)b
Controls Patients Controls
16048.87 (1989.18) 47014.73 (6395.26) 47862.50 (4818.93)
15773.68 (1960.96) 46597.27 (6766.11) 46807.53 (4788.16)
14275.03 (1803.94) 43358.57 (5253.97) 44940.76 (4817.45)
14183.13 (1731.98) 43539.14 (5047.07) 45196.03 (4879.04)0]
5]
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L. Gutiérrez-Galve et al. BIOL PSYCHIATRY 2010;68:51–60 554.98; p  .006), with an increase of 44.93 mm2 per IQ point
95% CI 19.89 to 69.97; p  .001). The superior (95% CI 10.35 to
4.85; p  .001), rostral middle (95% CI 6.38 to 20.87; p  .001),
nd caudal middle (95% CI .04 to 14.54; p  .049) parcellations
ccounted for the association. There was an increase of 30.37
m2 per IQ point (95% CI 5.33 to 55.41; p .017) in the temporal
ortical area. The middle (95% CI 3.87 to 14.17; p .001), inferior
95% CI 1.43 to 11.73; p  .012) and fusiform (95% CI 7.17 to
7.48; p  .001) parcellations accounted for this association.
ssociations remained significant after FDR correction for the
ight fusiform (95% CI 6.23 to 21.89; p  .012) and rostral middle
rontal (95% CI 5.27 to 23.86; p  .016) parcellations. No
ignificant associations were found in controls (Figures 2–6).
igure2. Scatter plot of the associationsbetweenpremorbid IQ and current
Q with the average cortical area for the right and left hemispheres in
atients and controls: superior frontal.In patients there was a significant association between corticalvolume and current IQ for frontal and temporal regions (mean
difference of regional volume increase per IQ point  33.72
mm3; 95% CI 5.84 to 73.28; p  .095), with an increase of
131.99 mm3 of frontal cortical area per IQ point (95% CI 57.62 to
206.35; p .001). The superior (95% CI 38.65 to 80.88; p .001),
rostral middle (95% CI 10.51 to 52.75; p  .003), and caudal
middle (95% CI .60 to 42.84; p  .044) parcellations accounted
for this association. Temporal cortical volume increased by 98.27
mm3 per IQ point (95% CI 23.90 to 172.63; p  .010) and the
superior (95% CI 2.87 to 36.04; p  .022), middle (95% CI 13.41
to 46.59; p  .001, inferior (95% CI 3.98 to 37.15; p  .015), and
fusiform (95% CI 22.49 to 55.66; p  .001) parcellations ac-
counted for this association. No significant associations were
present for controls.
Figure3. Scatter plot of the associationsbetweenpremorbid IQ and current
IQ with the average cortical area for the right and left hemispheres in
patients and controls: rostral middle frontal.
www.sobp.org/journal
a
i
r
e
t
i
1
p
p
7
c
F
I
p
56 BIOL PSYCHIATRY 2010;68:51–60 L. Gutiérrez-Galve et al.
wWorking Memory Span. In patients, there was a trend level
ssociation with larger frontal cortical area (281.43 mm2 increase
n area per score point; 95% CI 13.83 to 576.68; p  .062) that
eached significance when schizoaffective disorder patients were
xcluded (95% CI 8.99 to 696.42; p  .044).
In patients, there was a stronger association with frontal than
emporal cortical volume (mean difference of regional volume
ncrease per score point  569.12 mm3; 95% CI 123.13 to
015.11; p  .012), with an increase of 962.94 mm3 per score
oint (95% CI 86.24 to 1839.64; p  .031); the superior frontal
arcellation accounted for this association (95% CI 260.72 to
44.35; p  .001). No significant associations were present for
ontrol subjects.
igure4. Scatter plot of the associationsbetweenpremorbid IQ and current
Q with the average cortical area for the right and left hemispheres in
atients and controls: middle temporal.Cortical thickness was not associated with IQ or working
ww.sobp.org/journalmemory span. Scores of planning, working memory manipula-
tion, and Rey Auditory Verbal Learning Test were not signifi-
cantly associated with cortical parameters. There were no signif-
icant associations by side for any cognitive variable.
Discussion
Reduction in cortical volume, predominantly in temporal
regions, due to smaller cortical area in patients with first-episode
psychosis was our main finding, and area reductions were
closely related to cognitive performance. Cortical thinning was
only present in the right superior temporal region.
Our findings contrast with those of others reporting cortical
thinning in patients with childhood (66,67), early-adulthood, or
Figure5. Scatter plot of the associationsbetweenpremorbid IQ and current
IQ with the average cortical area for the right and left hemispheres in
patients and controls: inferior temporal.
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L. Gutiérrez-Galve et al. BIOL PSYCHIATRY 2010;68:51–60 57dult-onset (21,22) schizophrenia using SBM. The findings of
oets et al. (34), who reported reduced area and thickness in
verlapping cortical regions, are closer to our own. These
ifferences may be partly explained by the more severely
ompromised brain maturation trajectory in early onset schizo-
hrenia (68,69). Methodologic variations may also be relevant.
hus, surface measurements in native space from the Desikan
arcellations, used by Voets and colleagues (34) and ourselves,
ay be more sensitive than metric distortion used by others to
stimate changes in cortical area.
The human brain is characterized by an expansion in the size
nd complexity of association areas in the neocortex (70),
articularly prefrontal cortex (71), largely because of increased
igure6. Scatter plot of the associationsbetweenpremorbid IQ and current
Q with the average cortical area for the right and left hemispheres in
atients and controls: fusiform parcellations.ortical area with little change in cortical thickness (72). In earlyfetal development, cortical area is determined by the migration of
radial columns from the ventricular zone to the cortical plate
(73,74), followed by the asymmetrical division of precursor cells
in the ventricular zone and subsequent migration to the cortical
plate increasing its thickness but not its area. Although neuronal
migration is complete by the 25th week of gestation, glial
migration and growth of cortical connections continue for longer
with further increases in cortical surface, which is also influenced
by differential expansion of cortical layers (75). Our finding of
reduced area, without change in cortical thickness suggests a
disruption of corticogenesis at a time of rapid cortical expansion,
that is, late pregnancy and the perinatal period. Contemporary
white matter abnormalities may have further reduced cortical
area, as is thought to be the case in very low-birth-weight
adolescents in whom area reduction is greater than cortical
thinning (76,77). The reduction of brain volume over the first 2
decades of illness (78–80) suggests that mechanisms operating
around disease onset may also be relevant. Regional gray matter
changes may also be induced by atypical and typical antipsy-
chotics (81), although we failed to find an association with
treatment duration.
The pattern of cortical abnormalities reported here differs
from that in degenerative conditions. Cortical thinning without
area changes has been reported in early Huntington disease (18)
and in Alzheimer’s disease (85,86), validated at postmortem in
the latter using stereologic methods (87).
We did not find significant correlations between cortical
abnormalities and symptom severity, in keeping with other
(82,83), but not all (84), SBM studies, but we found a strong
association between IQ and frontotemporal cortical area. Gen-
eral intelligence depends on neural networks critically involving
frontal and parietal cortex (88,89). It has high heritability and
correlates strongly with gray matter volume (90,91) in normal
twins (92) and singletons (93). These studies have mainly
measured cortical thickness (94–96), which is modified by
experience-dependent plasticity (97). Cognitive impairment, in-
tegral to schizophrenia (98), is best characterized by a general-
ized deficit (99,100). Those with schizophrenia have lower IQs
than their childhood peers (101), and 40%–45% may decline
further by illness onset (102–107). This is supported by the closer
correlation between cortical area and current rather than premor-
bid IQ in our patients. We have previously reported that premor-
bid IQ and IQ at illness onset are prognostic indicators of clinical
outcome 3 to 4 years later (106,108). The association between
cortical area and IQ reported here suggests that cortical area
changes may have prognostic relevance.
There are limitations to our study. Abnormalities in other than
frontotemporal cortical areas cannot be excluded. It remains
possible, although unlikely, that changes in cortical thickness
could have been detected in a larger sample. However, Free-
surfer reliability studies (109) suggest that differences in cortical
thickness of less than .1 mm could have been detected with our
sample size. Moreover, in a more detailed, regional analysis,
cortical thinning was only present in one (the right superior
temporal) of several temporal parcellations with reduced area
suggesting that cortical abnormalities vary in different regions.
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